Agile Therapeutics Joins Forces with Insud Pharma
Agile Therapeutics has successfully merged with Insud Pharma’s US subsidiary, Exeltis USA, Inc., significantly enhancing its portfolio in women's health and contraceptive options.
Common shareholders of Agile Therapeutics will receive $1.52 per share of common stock, marking a rewarding conclusion to this acquisition.
Following the completion of the acquisition, Agile's common stock will no longer be listed on the OTC QB, as it transitions into a new chapter under Insud Pharma’s management.
Details of the Acquisition
Agile Therapeutics, Inc. (“Agile”) (OTCQB: AGRX), a leading company in women’s healthcare, has announced the successful completion of its acquisition by Insud Pharma, S.L., a global pharmaceutical entity. With over 45 years of experience and operations in more than 50 countries, Insud Pharma brings valuable expertise and resources to this merger.
The acquisition was approved by Agile's former common stockholders during a recent special meeting. As a result of this deal's closure, Agile shareholders will receive cash for their shares, leading to an estimated total enterprise value of $45 million.
This acquisition was carried out through the merger of Insud Pharma's wholly owned subsidiary with Agile. As a result, Agile will operate as an indirect subsidiary of Insud, ensuring continuity while enhancing the operational capabilities of both companies.
Background on Agile Therapeutics
Agile Therapeutics is dedicated to meeting the unmet health needs of women by offering innovative contraceptive solutions. The company's flagship product, Twirla, is designed to provide a non-daily contraception option, giving women more flexibility who prefer not to take a daily pill.
Twirla utilizes Agile’s proprietary Skinfusion technology, which allows for effective drug delivery through the skin. This product reflects Agile’s commitment to improving women's health and providing safe contraceptive options tailored to individual lifestyles.
Understanding Twirla
Twirla (levonorgestrel and ethinyl estradiol) is a once-weekly hormonal contraceptive patch. It is intended for women of reproductive age with specific BMI considerations, offering a significant alternative to daily pills. However, it is essential to consult healthcare providers regarding its proper use and effectiveness.
About Insud Pharma
Insud Pharma is a prominent player in the pharmaceutical industry, with a rich history and presence in approximately 50 countries. Employing over 9,000 individuals and operating 20 manufacturing plants, Insud Pharma demonstrates a strong commitment to healthcare.
The organization is engaged throughout the pharmaceutical value chain, focusing on scientific research, development, manufacturing, marketing, and sales of pharmaceutical products. Its commitment to enhancing global health is evident through ongoing investments in research and development, as well as cutting-edge technology.
Looking Ahead
The merger between Agile Therapeutics and Insud Pharma creates new opportunities for growth and expansion in the women's healthcare sector. The combined expertise and resources of both companies position them to enhance product offerings, innovate new solutions, and ultimately improve health outcomes for women worldwide.
Frequently Asked Questions
What is the purpose of Agile Therapeutics' merger with Insud Pharma?
The merger aims to strengthen Agile's capabilities in the women's health sector, expanding its contraceptive portfolio and improving access to innovative products.
What does the acquisition mean for Agile Therapeutics shareholders?
Shareholders will receive $1.52 per share in cash, providing a strategic exit from the public market and rewarding their investment.
Will Agile Therapeutics continue to operate after the merger?
Yes, Agile Therapeutics will continue its operations under the Insud Pharma umbrella, functioning as an indirect subsidiary.
How does Twirla work as a contraceptive solution?
Twirla is a transdermal patch that is applied once a week, offering a flexible and effective birth control option without the need for a daily pill.
What is Insud Pharma's business focus?
Insud Pharma focuses on the entire pharmaceutical value chain, providing specialized expertise in research, development, and production, along with effective and safe pharmacological treatments.
